Market Cap

BB Biotech AG Market Capitalization:

CHF3.15 Billion

CHF as of Jan. 1, 2023

US$3.41 Billion

business BB Biotech AG Company Profile

BB Biotech AG Main Stock Listing

show_chart SIX: BION

Market Capitalization History of BB Biotech AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of BB Biotech AG market cap

Date Market Cap YoY Change
Jan. 1, 2023 CHF3.15 B -15.19%
Jan. 1, 2022 CHF3.72 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

BB Biotech AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

BB Biotech AG has the following listings and related stock indices.


Stock: SIX: BION

Stock: MTA: BB

Stock: OTC: BBAGF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.